Organizational Chart of Roivant Sciences

Roivant Sciences

www.roivant.com

拥有270位主要高管和15家子公司 - Sumitomo Dainippon Pharma的子公司.
+41 432 155 999

添加高管

Roivant Sciences (ROIV) News

缺少什么？我们为您搜索。

打印或下载

Premium

Board

N-1

N-2

CEO

Matthew Gline
Move

Director

Melissa Epperly
Move

Director

Meghan Fitzgerald
Move

Director

Daniel Gold
Move

Director

Keith Manchester
Move

Director

James Momtazee
Move

Director

Ilan Oren
Move

CFO

Richard Pulik
Move

Accounting

R...
Move

President & COO

Eric Venker

Director @ Immunovant

Director @ Dermavant Sciences

Director @ Kinevant Sciences

Director @ Hemavant
Move

Commercial

A...

Commercial @ Telavant
Move

Communications

P...
Move

Development

S...

Development @ Telavant
Move

Priovant Therapeutics

B...

CEO @ Priovant Therapeutics
Move

CIO

D...
Move

Investment & Director

M...
Move

Special Projects

S...
Move

Health

A...

Director @ Lokavant
Move

Legal

J...
Move

HR

K...
Move

Lokavant

R...

CEO & Director @ Lokavant
Move

Clinical Operations

V...
Move

Vant

F...

Chairman of the Board @ Dermavant Sciences

Chairman of the Board @ Immunovant

Chairman of the Board @ Kinevant Sciences

Chairman of the Board @ Hemavant

CEO & Director @ Telavant
Move

发布 9月 7, 2024
Roivant Sciences是其次不到10成员。
从 [我的收藏] 中删除 Roivant Sciences

指出错误

筛选

存取

定制数据解决方案

决策者

企业

The Official Board